Reversal of asymptomatic over-anticoagulation by orally administered vitamin K

British Journal of Haematology

Volumn 133, Issue 3, 2006, Pages 331-336

  Baker, Peter ^a,b   Gleghorn, Ana ^a   Tripp, Teresa ^a   Paddon, Kevin ^a   Eagleton, Helen ^a   Keeling, David ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Asymptomatic; Over anticoagulation; Phytomenadione; Reversal; Warfarin

Indexed keywords

ALCOHOL; AMIODARONE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; HERBACEOUS AGENT; PHYTOMENADIONE; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIARRHEA; DIET; DRUG EFFICACY; FEMALE; HERBAL MEDICINE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PRIORITY JOURNAL; SELF MEDICATION; STRESS; THROMBOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN K 1; WARFARIN;

EID: 33645459101     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06029.x     Document Type: Article

References (16)

1. Baker R.I. Coughlin P.B. Gallus A.S. Harper P.L. Salem H.H. Wood E.M. the warfarin reversal consensus group 2004 Warfarin reversal: consensus guidelines, on behalf of the Australasian society of thrombosis and haemostasis. The Medical Journal of Australia 181 492 497.
2. British Committee for Standards in Haematology 1998 Guidelines on oral anticoagulation (warfarin): third edition. British Journal of Haematology 101 374 387.
3. British Committee for Standards in Haematology 2005 Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. British Journal of Haematology 132 277 285.q2
4. Cannegieter S. Rosendaal E. Wintzen A. Van Der Meer F. Vandenbroucke J. Briet E. 1995 Optimal oral anticoagulant therapy in patients with mechanical heart valves. New England Journal of Medicine 333 11 17.
5. Crowther M.A. Julian J. McCarty D. Douketis J. Kovacs M. Biagoni L. Schnurr T. McGinnis J. Gent M. Hirsh J. Ginsberg J. 2000 Treatment of warfarin-associated coagulapathy with oral vitamin K: a randomised controlled trial. The Lancet 356 1551 1553.
6. Crowther M.A. Douketis J.D. Schnurr T. Steidl L. Mera V. Ultori C. Venco A. Ageno W. 2002 Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulapathy. A randomized controlled trial. Annals of Internal Medicine 137 251 254.
7. Crowther M.A. Ageno W. Schnur T. Manfredi E. Kinnon K. Garcia D. Douketis J.D. 2005 Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin. Haematologica 90 137 139.
8. Eckman M. Levine H. Pauker S. 1993 Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. New England Journal of Medicine 329 696 702.
9. Linkins L.A. Choi P.T. Douketis J.D. 2003 Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Annals of Internal Medicine 139 893 900.
10. 1) in patients with excessive anticoagulation. Archives of Internal Medicine 163 2469 2473.
11. Makris M. Watson H.G. 2001 The management of coumarin-induced over- anticoagulation Annotation. British Journal of Haematology 114 271 280.
12. Palareti G. Leali N. Coccheri S. Poggi M. Manotti C. D'Angelo A. Pengo V. Erba N. Moia M. Ciavarella N. Devoto G. Berrettini M. Musolesi S. 1996 Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. The Lancet 348 423 428.
13. Patel R.J. Witt D.M. Saseen J.J. Tillman D.J. Wilkinson D.S. 2000 Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmocotherapy 20 1159 1166.
14. Poller L. Shiach C.R. MacCallum P.K. Johansen A.M. Munster A.M. Magalhaes A. Jespersen J. 1998 Multicentre randomised study on computerised anticoagulant dosage. European Concerted Action on Anticoagulation. The Lancet 352 1505 1509.
15. Watson H.G. Baglin T. Laidlaw S.L. Makris M. Preston F.E. 2001 A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of over-anticoagulation with warfarin. British Journal of Haematology 115 145 149.
16. Wilson S.E. Watson H.G. Crowther M.A. 2004 Low dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalised ratios: a brief review. Canadian Medical Association Journal 170 821 824.